MEPOLIZUMAB
NL83176.042.23
Approved small_molecule active
Quick answer
MEPOLIZUMAB for Eosinophilic Granulomatosis with Polyangiitis (eGPA) is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Eosinophilic Granulomatosis with Polyangiitis (eGPA)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active